Related Experiment Video
Updated: Feb 9, 2026
05:15
Inducing the Entry of Third Stage Dispersal Juveniles of Bursaphelenchus xylophilus into Cryptobiosis Through Osmotic Regulation
Published on: December 27, 2024
717
An update on juvenile dermatomyositis
V Boccaletti1, S Di Nuzzo, C Feliciani
1Clinica Dermatologica Università degli Studi di Parma, Parma, Italia - claudio.feliciani@unipr.it.
Abstract:
Juvenile dermatomyositis (JDM) is a rare, severe, autoimmune disease characterized by a small-vessel vasculopathy that primarily affects skin and muscle, but also lung, joints, gut and heart. Nowadays prompt recognition of this entity and aggressive treatment, when needed, improves outcomes and has decreased mortality that, before corticosteroid became a mainstay in therapy, could reach 40%.
